Finch Therapeutics Group Inc (FNCH) Company Profile & Statistics

Finch Therapeutics Group Inc
FNCH
(Nasdaq - US)
N/A
2.59
+0.28 (+12.15%)
in:usd•As of: May 02, 2024 10:54 UTC -4
Open
2.39
High
2.59
Low
2.39

About Finch Therapeutics Group Inc

CEO

Matthew P. Blischak

Headquarters

75 state street, suite 100

boston, ma 02109, united states

Auditor

Wolf & Company, P.C.

Employees

Share Holders

Website

www.finchtherapeutics.com

Industry

medical or nursing services

Sector

health services

Company Overview

Finch Therapeutics Group Inc. is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery(R) platform to develop a novel class of orally administered biological drugs. The company's product candidate includes CP101, FIN-211, FIN-524 and FIN-525. Finch Therapeutics Group Inc. is based in SOMERVILLE, Mass.

Finch Therapeutics Group Inc Statistics

Valuation Measures

Market Capitalization ²	4.17M
Enterprise Value	-20.95M
Enterprise Value/EBITDA (ttm)	0.25
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.16
Price to Sales (ttm)	5.86
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	25.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-14939.02%
Return on Equity (ttm)	-136.63%
Return on Invested Capital (ttm)	-234.64%
Return on Assets (ttm)	-57.40%

Income Statement

Revenue (ttm)	107.00K
Revenue Per Share (ttm)	0.07
Gross Profit (ttm)	107.00K
EBITDA (ttm)³	-82.34M
Net Income Avi to Common (ttm)	-74.75M
Diluted EPS (ttm)	-47.67

Share Statistics

Beta (5Y Monthly)	0.46
52-Week Change	-77.85%
S&P500 52-Week Change	24.15%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	1.61M
Dividend Yield	0.00%
Float ⁴	885.00K
% Held by Insiders	44.90%
% Held by Institutions	21.77%

Balance Sheet

Total Cash (mrq)	25.12M
Total Cash Per Share (mrq)	15.65
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	6.33%
Quick Ratio (mrq)	6.33%
Book Value Per Share (mrq)	14.25

Cash Flow

Operating Cash Flow Per Share (ytd)	-19.63
Free Cash Flow (ytd)	-30.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Finch Therapeutics Group Inc

Trade With A Regulated Broker